Invention Grant
- Patent Title: Bacteria engineered to reduce hyperphenylalaninemia
-
Application No.: US15260211Application Date: 2016-09-08
-
Publication No.: US09943555B2Publication Date: 2018-04-17
- Inventor: Dean Falb , Vincent M. Isabella , Jonathan W. Kotula , Paul F. Miller , Yves Millet , Sarah Rowe
- Applicant: Synlogic, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Synlogic, Inc.
- Current Assignee: Synlogic, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Main IPC: A61K35/741
- IPC: A61K35/741 ; C07K14/245 ; C12R1/19 ; A61K35/74 ; C12N9/88 ; C12N9/06 ; C12N15/70 ; A61K35/00
Abstract:
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
Public/Granted literature
- US20170014457A1 Bacteria Engineered to Reduce Hyperphenylalaninemia Public/Granted day:2017-01-19
Information query
IPC分类:
